Bourgeois Alexandra, Lemos Juliana Aline Souza, Roucheray Stéphanie, Sergerie Audrey, Richard Dave
Centre de Recherche en Infectiologie, CRCHU de Québec-Université Laval, Quebec City, QC G1V 4G2, Canada.
Department of Microbiology-Infectious Diseases and Immunology, Faculty of Medicine, Laval University, Quebec City, QC G1V 0A6, Canada.
Infect Dis Rep. 2024 Jun 26;16(4):543-560. doi: 10.3390/idr16040041.
Parasitic diseases, such as malaria, are an immense burden to many low- and middle-income countries. In 2022, 249 million cases and 608,000 deaths were reported by the World Health Organization for malaria alone. Climate change, conflict, humanitarian crises, resource constraints and diverse biological challenges threaten progress in the elimination of malaria. Undeniably, the lack of a commercialized vaccine and the spread of drug-resistant parasites beg the need for novel approaches to treat this infectious disease. Most approaches for the development of antimalarials to date take inspiration from tropical or sub-tropical environments; however, it is necessary to expand our search. In this review, we highlight the origin of antimalarial treatments and propose new insights in the search for developing novel antiparasitic treatments. Plants and microorganisms living in harsh and cold environments, such as those found in the largely unexploited Northern Canadian boreal forest, often demonstrate interesting properties that are not found in other environments. Most prominently, the essential oil of spp. from Nunavik and mortiamides isolated from species found in Nunavut have shown promising activity against .
疟疾等寄生虫病给许多低收入和中等收入国家带来了巨大负担。2022年,仅疟疾这一种疾病,世界卫生组织就报告了2.49亿例病例和60.8万例死亡。气候变化、冲突、人道主义危机、资源限制和各种生物挑战威胁着疟疾消除工作的进展。不可否认的是,缺乏商业化疫苗以及耐药寄生虫的传播使得需要新的方法来治疗这种传染病。迄今为止,大多数抗疟药物的研发方法都借鉴自热带或亚热带环境;然而,有必要扩大我们的探索范围。在这篇综述中,我们强调了抗疟治疗的起源,并在寻找新型抗寄生虫治疗方法方面提出了新的见解。生活在恶劣寒冷环境中的植物和微生物,比如在加拿大北部大片未开发的北方针叶林中发现的那些,常常展现出在其他环境中未发现的有趣特性。最显著的是,来自努纳维克的 spp. 的精油以及从努纳武特发现的 物种中分离出的mortiamides,已显示出对 有前景的活性。